Walter Jeske - Concepedia

Author

Walter Jeske

Loyola University Medical Center ORCID

Also Known As

Daniel Kahn, W JESKE, W Jeske, W P Jeske, W. JESKE, W. Jeske, W. P. Jeske, W.P. JESKE, W.P. Jeske, Walter Jeske

441

Publications

4.6K

Citations

H-Index

123

Concepts

All Affiliations

Loyola University Medical Center Loyola University Chicago Rensselaer Polytechnic Institute Sanofi (France)

About

Walter Jeske is an author at Loyola University Medical Center specializing in medicine, pharmacology, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	54	1.7K
2	Health Sciences	4	4	87
3	Natural Sciences	4	4	116
4	Engineering	3	3	43
5	Education	1	1	47

Walter Jeske

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
The Society of Thoracic Surgeons Practice Guideline Series: Aspirin and Other Antiplatelet Agents During Operative Coronary Revascularization (Executive Summary)* Victor A. Ferraris, Suellen P. Ferraris, David J. Moliterno, The Annals of Thoracic Surgery Percutaneous Coronary InterventionThrombosisCardiothoracic SurgeryCardiovascular DiseaseCoronary Artery Disease	2005	154
Acute Onset Human Atrial Fibrillation Is Associated With Local Cardiac Platelet Activation and Endothelial Dysfunction Joseph G. Akar, Walter Jeske, David J. Wilber Journal of the American College of Cardiology ThrombosisCardiovascular DiseaseEndothelial DysfunctionVascular BiologyAcute Myocardial Infarction	2008	148
Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus Deepak L. Bhatt, Jing-fei Dong, Douglas Logan, Journal of the American College of Cardiology Diabetes ManagementMedicineDiabetesType 2Enteric Coating	2017	146
Synthetic Pentasaccharides Do Not Cause Platelet Activation by Antiheparin-Platelet Factor 4 Antibodies Sarfraz Ahmad, Walter Jeske, Jeanine M. Walenga, Clinical and Applied Thrombosis/Hemostasis	1999	77
Affinity purification of heparin‐dependent antibodies to platelet factor 4 developed in heparin‐induced thrombocytopenia: biological characteristics and effects on platelet activation Jean Amiral, Claire Pouplard, Anne Marie Vissac, British Journal of Haematology	2000	73
Rivaroxaban – an oral, direct Factor Xa inhibitor – has potential for the management of patients with heparin‐induced thrombocytopenia Jeanine M. Walenga, Margaret Prechel, Walter Jeske, British Journal of Haematology	2008	73
Troponin I Levels in Patients with Preeclampsia Dominique Joyal, Ferdinand Leya, Megan Koh, The American Journal of Medicine Maternal Cardiovascular OutcomeGynecologyMaternal HealthMaternal-fetal MedicineEclampsia	2007	66
Laboratory Diagnosis of Heparin-Induced Thrombocytopenia Jeanine M. Walenga, Walter Jeske, Anthony R. Fasanella, Clinical and Applied Thrombosis/Hemostasis	1999	66
The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular-weight heparin D. Hoppensteadt, Walter Jeske, Jawed Fareed, Blood Coagulation & Fibrinolysis	1995	62
Laboratory tests for heparin-induced thrombocytopenia: a multicenter study. Jeanine M. Walenga, Walter Jeske, Jennifer J. Wood, PubMed	1999	61

Page 1